These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma. Magnotti LJ, Schroeppel TJ, Clement LP, Swanson JM, Bee TK, Maish GO, Minard G, Zarzaur BL, Fischer PE, Fabian TC, Croce MA. J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914 [Abstract] [Full Text] [Related]
3. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit? Wahl WL, Franklin GA, Brandt MM, Sturm L, Ahrns KS, Hemmila MR, Arbabi S. J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523 [Abstract] [Full Text] [Related]
4. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL. Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997 [Abstract] [Full Text] [Related]
5. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study. Nseir S, Deplanque X, Di Pompeo C, Diarra M, Roussel-Delvallez M, Durocher A. J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975 [Abstract] [Full Text] [Related]
6. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK, Monaghan SF, Adams CA, Stephen A, Connolly MD, Gregg S, Cioffi WG, Heffernan DS. J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [Abstract] [Full Text] [Related]
8. Surveillance culture utility and safety using low-volume blind bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Boots RJ, Phillips GE, George N, Faoagali JL. Respirology; 2008 Jan; 13(1):87-96. PubMed ID: 18197916 [Abstract] [Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Shorr AF, Combes A, Kollef MH, Chastre J. Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656 [Abstract] [Full Text] [Related]
10. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia. Raghavendran K, Wang J, Belber C, Misra SR, Brunton K, Berbary E, Burke MS, Haas CE. J Trauma; 2007 Jun; 62(6):1377-82; discussion 1382-3. PubMed ID: 17563652 [Abstract] [Full Text] [Related]
11. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study]. Fekih Hassen M, Ayed S, Ben Sik Ali H, Gharbi R, Marghli S, Elatrous S. Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848 [Abstract] [Full Text] [Related]
12. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. Nicasio AM, Eagye KJ, Nicolau DP, Shore E, Palter M, Pepe J, Kuti JL. J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167 [Abstract] [Full Text] [Related]
13. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? Eachempati SR, Hydo LJ, Shou J, Barie PS. J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237 [Abstract] [Full Text] [Related]